OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
175 Crossing Blvd.
Carol A. Ziomek, PhD is vice president for development at GTC Biotherapeutics, Inc.
Capital investments in production plants represent a significant portion of the cost of new recombinant drugs